The use of pigs as research animals in survival surgery has increased greatly in the last 15 years. Personnel conducting pig research have been hampered by a lack of proven longacting analgesics for treatment of surgical pain of longer duration, and bya lack of reliable non-subjective parameters for the assessment of pain relief. The efficacy of the mixed opioid agonist-antagonist buprenorphine hydrochloride 0.10 mg/kg pm (n = 2) in the treatment of post-thoracotomy pain was compared with that of a trans dermal therapeutic system (TTSI delivering 25 {tg/h (n = 3) or SOflg/h (n = 2) of the mu opioid agonist fentanyl hydrochloride.
the lack of availability of safe, effective and potent analgesic drugs for the treatment of pain of long duration.
In addressing the first problem, clinicians have adapted clinical scoring systems which are subjective due to experiential bias in their application, e.g. the scoring system proposed by Morton and Griffiths (1985) . More recently welsh et a1. (1993) adapted human linear pain scoring techniques for the assessment of pain associated with foot rot in sheep. In many human analgesiometry studies the patient self-reports pain, however animals are unable to do this, although preference testing is an emerging technique which may permit a form of self-reporting of animal pain. Evaluation of animal behaviour time budgets may allow objective assessment of painful and stressful events. Fraser et a1. (1991) demonstrated decreased aggression in growing pigs kept on straw bedding versus raised deck flooring using time budget analysis.
In attempting to measure the impact of pain and other aversive phenomena, animal scientists have analysed economic or production parameters such as feed consumption and weight gain. While these variables are significant they share the disadvantage of being impacted by many factors other than pain state, such as stress level and intercurrent disease (McGlone et a1. 1993) . Physiological parameters such as measures of the hypothalamic-pituitary-adrenal axis using cardiovascular and endocrine measures, and more recently neurophysiological correlates of pain such as somatosensory evoked potentials have been employed for the assessment of pain (Breazile 1987 ) but lack specificity for pain alone and are unwieldy in clinical situations.
The creation of rodent pain models employing standardized painful stimuli for pharmacological and neurophysiological investigation, has resulted in highly repeatable pain studies at the basic science level (Franklin & Abbott 1989) . In the research setting pain is also frequently an undesired by-product of experimental manipulations such as surgery, and can represent an uncontrolled confounding variable. Postoperative pain in laboratory animals has the 387 potential to be opportunistically investigated in a methodical fashion IFlecknellI984). The profound effects of unresolved pain on neurohumoral responses are well established in man and animals. Anand et a1. (1990) demonstrated higher post-operative mortality in human infants with poor, as opposed to effective, pain control.
Because of size, logistical difficulty, economics and lack of economic incentive, large non-equine farm animals have not been studied to the same extent as companion animal and laboratory animal species in clinical pain research. In the provision of analgesia, the focus of concern has tended to be on the horse, dog and cat, on small laboratory animals, and on short-term studies with large numbers of subjects focused on acute or phasic types of pain. Hence comparatively little is known about the response of farm animal species to chronic pain and correspondingly little is known about analgesia in these species. This knowledge gap is a serious issue because farm animal species, particularly pigs, are displacing companion animal species in research (Swindle et a1. 1994) . In 1980, 12205 pigs were used in research in Canada, while by 1995, 38935 were used annually, despite an overall decrease in total numbers of animals used for research in the same period. The numbers of dogs used decreased from 10 488 to 7333 over the same time period (CCAC 1999) .
A variety of behavioural changes are associated with the pain state in pigs (CCAC 1993) . Acute phasic pain is usually accompanied by vocalization and vigorous flight response. Signs of tonic pain may be more subtle and refer to the perturbed system, consisting of a combination of changes in gait, posture, behaviour and state/activity level. For example, gait and postural alteration may include walking on tiptoe, decreased velocity of movement, guarding the abdomen following laparotomy or deflection of the operated side following thoracotomy. General behaviour changes associated with pain may include inactivity and recumbency, aggressiveness, depression, head pressing, coprophagy, stereotypic chewing and other stereotypies as well as a tendency to isolate from conspecifics or to avoid social interaction. Changes in activity level and state may include increased recumbency time, reluctance to move or change position, lack of response to humans and other pigs, and decreased or absent food and/or water consumption.
There has been a limited amount of research focused on relatively brief, phasic pain in pigs, such as the pain associated with castration and other routine agricultural husbandry practices. One study (McGlone & Hellman 1988) revealed that the use of general anaesthesia in piglet castration resulted in death in 28% of 2-week-old piglets, and that surviving piglets had suppressed nursing behaviour. In the same study, the use of local and general anaesthesia and non-steroidal anti-inflammatory analgesics (NSAIAs) did not suppress castration-induced behaviour changes in 7-week-old piglets in the 8 h postoperative monitoring period.
There have been few efforts to characterize behaviour changes associated with tonic pain in pigs and to develop strategies for long-term pain relief in this species, despite the susceptibility of pigs to more prolonged pain in surgical and other chronic studies. In laboratory animals such as rats, approaches such as the Disturbance Index method have been developed to objectively assess the effects of standard manipulations on behaviour and activity level (Barclay et a1. 19881. Pigs frequently undergo major experimental surgery such as orthopaedic procedures, laparotomy and abdominal surgery, thoracotomy and organ transplantation and may experience considerable post-operative pain in the first 48-72 h after surgery. The severity of pain generally requires opioid analgesic treatment. The use of NSAIAs in some cases is not acceptable in studies investigating immunoregulation and wound healing (Dahl & Kellet 1991) . Other options include the use of long-acting local anaesthesia by infiltration, spray or topical application. Most opioid-agonist and mixed agonist drugs, e.g. morphine, have short serum half-lives in pigs, generally less than 4h of effective serum concentration after administration [Hermansen et a1. 1986 ). The limited duration of efficacy means that continuous delivery or frequent injection is Laboratory Animals (2000) 34 Harvey-Clark, Gilespie & Riggs required to maintain effective serum levels. In practice animals may receive analgesics which are effective for only 4-6 h, and even when treated late in the afternoon may not receive another analgesic dose for an overnight interval of 14-16h, by which time they are at risk from 'breakthrough pain', when serum analgesic concentrations fall below the effective therapeutic level. The requirement for frequent restraint and administration of short-acting analgesics causing distress in labile swine can obviate the beneficial effects of the analgesic. The use of continuous intravenous infusion analgesics in farm animals such as pigs necessitates either continuous restraint or sophisticated jacket infusion pump apparatus which can be stressful, costly and unwieldy.
The narcotic agonist-antagonist compound buprenorphine hydrochloride is a long-acting opioid which provides extended analgesia from a single injection, and has gained favour among laboratory animal clinicians in several species for longer-term pain control. Buprenorphine 0.12 mg/kg by intramuscular (i.m.l injection has a duration of action from 7-24 h in blocking thermal and mechanical phasic pain in domestic swine (Hermansen et a1. 1986) . However it has a shorter duration than previously thought in the dog (as little as 4 h) and fails to produce appreciable analgesia in some animals (Waterman & Kalthum 1992) . There have been few studies on the pharmacokinetics or efficacy of this compound in pigs.
Transdermal therapeutic systems for the delivery of the narcotic analgesic fentanyl citrate were licensed in 1992 in Canada for the treatment of cancer pain in man. Fentanyl is a potent short-acting synthetic narcotic with mu receptor agonist effects. The potency of fentanyl in man is 7S times that of morphine on an equi-analgesic basis, and because the drug is lipophyllic, selective distribution occurs to the brain, stratum corneum and dermis of the skin which are lipid rich tissues (Calis et a1. 1992) . In man the drug is eliminated primarily by hepatic biotransformation (Lehman & Zech 1992) . Lipid solubility through the skin makes it suitable for administration by TIS or 'skin patch' delivery system. The patch employs a layer of skin adhesive with a priming dose of fentanyl, covering a rate-limiting membrane which releases the drug at 2.5 j.tg/h/cm 2 of skin. Once applied, fentanyl is absorbed into the tissues, forming a local depot which releases the drug into the circulation by capillaries (Hill 1990 ). The bioavailability of fentanyl approximates a steady-state infusion similar to that delivered by continuous intravenous administration in man, once the equilibration period of 6-12h has passed (Simmonds et al. 1988) . In humans effectively treated with TTS fentanyl, serum concentrations are in the range of 0.5-2.0 ng/ml and can be sustained for up to 48 h after the application of a single patch (Calis et al. 1992) . These serum levels are lower than levels associated with the anaesthetic state, in the range of 50-80 ng/ml in man. There are little data on TTS fentanyl pharmacokinetics in non-human subjects.
There are several reasons to believe that pigs could achieve absorption of fentanyl from trans dermal patches in a manner similar to humans. Unlike most domestic species in which the majority of the skin surface has an indirect blood supply in the form of perforating branches of vessels from underlying tissues such as muscles. Pigs, like humans, have an extensive direct musculocutaneous arterial supply (Daniel & Williams 19731 ,an anatomical similarity which implies that absorption and distribution of transdermal therapeutic agents from the epidermis and dermis in pigs may be similar to that seen in man. Panchagnula et al. (1997) determined that pig skin was moderately permeable to both polar and non-polar compounds.
Few studies have been published on the single-dose pharmacokinetics of parenteral fentanyl in the pig. Koren et al. (1987) studying halothane-anaesthetized pigs generated pharmacokinetic data for fentanyl which provided the basis for the initial patch dose employed in this study, 25 j.tg/hpatch in pigs of 20-30 kg. This limited pharmacokinetic study indicated that to achieve a serum steady-state concentration of 0.5-2 ng/ml in the pig, and assuming transdermal kinetics mimic i.v. infusion kinetics in man, an infusion rate equivalent to 2.18-8.70j.tg/h in a 30 kg pig would be required (see Appendix I 389 for calculations). Therefore the initial patch dose selected in this study was the lowest dose patch size available, 25 j.tg/hfor 25-30 kg pigs, approximately three times the predicted high dose required. The purpose of this study was to compare the efficacy of two doses of TIS fentanyl with buprenorphine as a postsurgical analgesic in pigs using blinded pain score, food consumption, frequency of movement and activity levels. In addition, serum levels of fentanyl were measured during the post-operative period in TIS fentanyl treated pigs.
Materials and methods
All experiments involving animal use were conducted in accordance with guidelines in the Canadian Council on Animal Care Guide to the Care and Use of Experimental Animals Volume 1 (1993) and under approved institutional animal care protocols. Helminth and mycoplasma-free Yorkshire cross white female pigs (weight 26.2± 2.1 kg, mean± SD) from a single commercial farm source were used. The animals were conventionally housed in a closed-system indoor facility with 50± 10% relative humidity, 15 air changes per hour (100% fresh air system) and temperature of 22± 1°C. Pigs shared fenceline contact with another familiar pig and were singly housed in 2 x 2 m pens on elevated Tenderfoot R vinyl covered expanded mesh flooring with ad libitum access to chlorinated tap water from nipple waterers and hog grower ration (Shurgain Grower) fed to a maximum of 2 kg per day in a single morning feeding. No contact bedding was supplied but clean towels were supplied for nesting and a plastic jug on a chain was supplied for environmental enrichment. Light was supplied via ceiling florescent fixtures on a 12:12 schedule, lights on at 07:00 pacific daylight time (PDT), with a 5 lux red light mounted at the rear of the observation pen turned on 24 h per day to permit 24 h videotaping of behaviour. A colour video camera (Sony TR81) with a wide angle lens was mounted 2 m above the pen and behaviour recorded using a 24h VCR (JVCSR-L900U)with a sampling interval of 0.6 s and a time code in hours/minutes/seconds recorded on the tape. In order to prevent observer bias, all animals received an opaque occlusive dressing placed over the interscapular patch application site to mask the area.
The experimental design was a modified Latin square using each pig as its own control, and with serial treatments consisting of no treatment (n = 7), analgesic alone preoperatively, and analgesic post-operatively for 3 consecutive days. Animals were randomized to analgesic treatment after the control period. Analgesics used were buprenorphine hydrochloride 0.10 mg/kg i.m., n = 2; TIS fentanyl 25 jig/h, n = 3, and TTS fentanyl 50 jig/h, n = 2. Ethical guidelines did not permit the withholding of analgesia from post-operative animals; rather, animals in the control group were treated with the parenteral opioid buprenorphine hydrochloride 0.10 mg/kg i.m. to effect. Animal behaviour was assessed by blinded analysis of videotapes. An observer ignorant of the treatment viewed all the videotapes (120h per pig in the study) and manually recorded the durations of specific activities in real time from the tape in hours, minutes and seconds chronologically using a score sheet. Pigs were considered to be either active (defined as being in the standing position, moving, engaging in behaviours such as eating, drinking, or playing) or inactive (defined as being in ventral or lateral recumbency, or not moving, whether awake or asleep). Postural change was defined as the change from active to inactive state or vice versa. Data were transferred to a spreadsheet program (Microsoft Excel Version 5.0) for manipulation purposes, graphs were created using Kaleidagraph software and analysis of variance (ANOVA)was conducted using SPSS software.
After a minimum of 5 days of acclimatization pigs were videotaped for 24 h in the home pen prior to surgery and analgesic treatment . Four days prior to surgery animals were randomized to receive one of three treatment regimens; buprenorphine 0.1 mg/kg i.m., trans dermal fentanyl 251lg/h or 50 jig/h. Each animal received 24 h treatment with the analgesic in the absence of pain (designated Laboratory Animals (2000) 34 Harvey-Clark, Gilespie & Riggs 'analgesic alone' in Figs 3-5). Animals receiving buprenorphine were injected the previous evening and at 07:00/19:00 h the day of treatment and videotaping. Animals receiving TTS fentanyl had a patch applied the afternoon before being videotaped. The pre-operative analgesic treatment in the absence of pain/surgery was applied for a 24h period of videotaping. Following this treatment the patch was removed or injection discontinued, and the animals had a minimum of 48 h to clear serum fentanyl levels before surgery. On the morning of surgery (day 1), following a 12-14h overnight fast, pigs were sedated at approximately 08:00 h with ketamine 20 mg/kg i.m. and anaesthesia induced with 4% isoflurane in oxygen by mask. Following intubation with a cuffed 10mm endotracheal tube, anaesthesia was maintained at 1-2% isoflurane in 45% oxygen and air. Following induction a transdermal fentanyl patch (Duragesic 25 or 50 Ilg/h, Janssen Pharmaceutica Inc., Mississauga, Ontario, Canada) was applied to the intrascapular area after skin cleansing with chlorhexidine gluconate 2% surgical soap (Hibitane) and 95% isopropyl alcohol. Animals in the buprenorphine-treated group received a single i.m. injection of 0.1 mg/kg i.m. buprenorphine hydrochloride (Temgesic, Rickett and Colman, UK) at the same time. The left hemithorax was aseptically prepared and a left lung allograft transplant performed by an experienced transplant surgeon. A subcutaneously implanted vascular access port catheter (Model LCI vascular access port, Access Technologies, Skokie Illinois, USA) was implanted in the left jugular vein/anterior vena cava for blood sampling and infusion and the access chamber placed subcutaneously at the base of the left ear. Identical surgical teams and procedures were used for all surgeries. Recovery from surgery occurred 4-5 h after induction.
Subjective pain scoring was conducted twice daily during the recovery period by an experienced observer, unaware of the treatment using a scoring system based on that of Morton and Griffiths (1985) .Animals scoring above the threshold level of 15 in this system received supplemental analgesic treatment with buprenorphine hydrochloride
Evaluation of state: pain and narcosis
At no point in the study was respiratory depression, hypoxia or other manifestations of narcotization observed during routine daily veterinary examination. In evaluating pain and individual response to analgesics the dependent variables were numerical pain score averaged on each day from two observations, the weight of food consumed on each day [maximum 2 kg), average intervals (Fig 1) Pigs which received 25 and 50~g/h TTS fentanyl patches at 07:30 h had measurable serum concentrations of analgesic by 14:00-16:00h the same day, approximately 2h after surgical recovery and 6.5-8.5 h after patch application. Serum levels were at or above the lower limit of the recognized human analgesic level (0.5ng/ml) by 8-lOh after administration in pigs receiving 50~g/h patches. Maximum serum fentanyl levels depended on the dose of patch used; in female pigs of 25-30 kg body weight, the 25~g/h patch did not consistently deliver serum levels in the range recognized as analgesic in man, i.e. 0.5-2.0ng/ml, but levels tended to fall to between 0.1-0.3ng/ml. At a dose of 50 j1g/h serum fentanyl levels exceeded 0.5 ng/ml for the majority of the post-operative period and this corresponded to adequate clinical pain control (see Fig 3) . In one pig treated with a 25 j1g/h patch (Pig 2 in Fig 1) the patch became detached, and serum levels of the drug fell rapidly. Serum levels remained in the analgesic range after 48 h of patch application in both animals treated with 50~g/h patches, but decreased after 48 h. In the case of both patch doses, serum fentanyl levels had decreased to undetectable levels 72 h after patch removal. sensitive and selective modified gas chromatographic assay using mass selective detection was developed for the accurate quantitation of fentanyl in swine serum with a quantitation limit of 0.05 ng/ml (Szeitz et al. 1995) . Serum levels of buprenorphine hydrochloride were not assessed. . . between each major movement in minutes and seconds over 24 h on each day of treatment, and the percentage of 24 h spent active on each day.
Results

Serum [fentanyl]
Pain score (Figs 2-4)
Average pain scores for each of the three treatments were negligible in the pre-operative control and 'analgesic alone' treated groups. Post-operatively, animals receiving buprenorphine required 'top-up' doses of analgesic recovery, 5-8 h after the initial dose, indicating that this agent at the doses used may not consistently provide 12 h of analgesia. On all three post-operative days all animals had acceptable pain control (defined as scores of 15 or less), the only group scoring consistently above 5 on the scale were animals treated with 25 f.lgjh fentanyl patches. Apart from one pig with a detached patch, these animals did not score near or above IS, the level at which supplemental injectable analgesia using buprenorphine was automatically employed. Animals treated with buprenorphine 0.10 mg/kg pm had acceptable pain scores and fell within the range considered adequate for pain control (pain score 3-6). Pigs treated with 25 f.lg/h patches had pain scores in the highest range (7-141 and those treated with 50 f.lgjh patches had the lowest pain scores (range 1-3) on all 3 days post-operatively. Two animals treated with a 25 f.lgjh patch (Fig 3) had pain scores which approached the unacceptable range on days 2 and 3 and were effectively treated with supplemental buprenorphine. However subsequent serum analysis indicated that the blood levels of fentanyl observed in the third animal receiving 25 f.lgjh fentanyl patch (Pig 12, Fig 1) were very low due to patch detachment. 
Food consumption
Pigs ate the majority of their ration within minutes of presentation when untreated or treated with analgesic alone, regardless of analgesic and dose. Food intake averaged 1.93 kg prior to study and 1.95 kg with analgesic treatment alone. In the post-operative period food consumption was depressed in all three treatment groups and increased slowly and progressively over 3 days. By day 3 food intake was still only 25-30% of normal, except in one of the buprenorphine-treated animals (P20), where it was approximately 60%. This animal had a high pre-operative activity level and increased food intake.
Activity
Pigs were highly variable in their activity levels prior to any manipulation, with a range from 9.5-31.5% of a 24h day. One of the two pigs receiving buprenorphine analgesia (P20) had abnormally high activity levels prior to the study. With fentanyl or buprenorphine treatment alone, activity levels did not change significantly in any of the treated animals. The pigs showed variable responses to surgery and analgesia in terms of activity, however animals with low post-operative pain scores tended to be less active. However on the first post-operative day, activity levels were lower in animals treated with 25,ug/h fentanyl, and were equal to or higher in pigs given 50 ,ug/h than in the control groups. One animal given buprenorphine had slightly increased activity on day I, while the other was less active. By the end of day 3, all animals had returned to pre-treatment activity levels of 10-20%.
Time interval between major movements
Untreated pigs averaged 11.6 min between each major postural movement over 24 h (mean of 123 movements per day), with longer intervals of up to 30 min in the sleeping hours between 24:00 and 06:00 h. During the morning when pigs were fed, pens were cleaned and interaction with humans occurred, intervals between major movements decreased to as littl~as 3 s in duration. The time period between major movements over 24 h was between 6 and 34 min in the control and analgesic-treated groups. However post-operatively, the interval increased up to three or four-fold. ANOVA did not reveal treatment-specific differences between any of the groups within any single day. On day 1 of post-operative treatment, there was a noticeably greater interval between movements in the 50/lg/h treated pigs versus the other two treatments, not considered statistically significant. On days 2 and 3, although intervals were elevated two to three-fold, differences between treatment groups were not significant. The general trend over days 2 and 3 was a decrease in interval, except in the 25/lg/h fentanyl group, where the longest average intervals were seen on day 2.
Discussion
In investigating the utility of TTS fentanyl in the control of post-operative pain in pigs, this study used both non-subjective measures as well as subjective blinded assessment methods. Serum data in this study demonstrate that pigs are capable of absorbing fentanyl from existing, inexpensive commercially available TTS patches, but that absorption kinetics differ greatly from predictions based on anatomical and physiological similarities with human skin and published i.v. pharmacokinetic data on fentanyl in pigs (see Appendix I). Pigs which received patch doses approxi-Laboratory Animals (2000) 34 mately three times higher than the dose which was predicted to yield serum levels in the 2 ng/ml range, failed to achieve peak serum concentrations above 0.6 ng/ml. In most instances serum concentrations in these animals were in the 0.2-0.3 ng/ml range, approximately 10% of the predicted concentration based on predictions. This indicates that either the absorption of fentanyl from TIS systems implanted in the intrascapular region differs between pigs and humans, or that fentanyl clearance differs from that predicted by published data.
Concerns that valuable research animals might ingest patches and become dangerously narcotized were not realized. The site chosen for patch placement, in the intrascapular area, has thicker skin which may impede drug absorption versus other sites, however this area is convenient for access and security. Patches applied in this area are difficult for the pig to remove, however the difference in absorption predicted by published kinetics data may be explained in part by the thicker skin in this area impeding absorption and circulation of TTS fentanyl. The cornified epithelial layer is the main barrier to fentanyl absorption (Lehman & Zech 1992Land the intrascapular area is one of the areas of pig skin where this layer, and the full thickness of the skin, is greatest. However in vitro trans dermal permeability tests of animal and human skin indicate that skin thickness alone may not be related to relative permeability values for polar compounds (Panchagnula et al. 1997). Pain control in female pigs treated with 25 j.tg/h patches in the weight range of this study (26.2±2.l kg) was barely adequate and in one case required supplemental analgesia. In animals treated with 50 j.tg/h TTS fentanyl, achieving higher serum levels above 0.5 ng/ml, pain control was adequate. This indicates the serum fentanyl lower threshold associated with adequate pain control in the domestic pig may be similar to that seen in man, in the range of 0.3-0.6 ng/ml.
If TTS patches detach from the underlying skin, absorption of fentanyl is interrupted and serum levels fall. It is recommended that a clear occlusive dressing be used over the patch in clinical situations in order to assess 395 the attachment site, to ensure good skin attachment and drug absorption, and to ensure the close attachment of the patch to the skin. It appears that the patch can achieve reliable serum concentrations for 48-72 h post-operatively_ In man the patch is regarded as a 48 h treatment, however it appears that in pigs the patch will deliver fentanyl at analgesic concentrations for 72h. This corresponds to the usual decrease in post-operative pain commonly observed between 48 and 72h following major, nonorthopaedic surgery cases ICaroI1999).
At no point in this study were respiratory depression, hypoxia or other manifestations of narcotization clinically detected during daily physical examinations, which may be due to the conservative patch dosage. Similarly signs of central nervous system (CNS) stimulation, vocalization and other dysphoric behaviour reported with administration of certain opioids in porcine species (Hermansen et al. 1986) were not noted in this study.
We recommend that 50 j.tg/h TTS fentanyl be used in pigs weighing 25-30 kg. Due to individual variation in response to opioids, in some instances this dose level may provide only basal analgesia. Similar variation in analgesic dose response with equivalent doses of TIS fentanyl has been observed in man (Gourlay et al. 1988) . Depending on the invasiveness of surgery, severity of pain and morbidity, age, condition, fat content and sex of the pig and other factors, TTS fentanyl in pigs may be useful as basal, pre-emptive analgesia. In some instances of more severe pain, e.g. after orthopaedic surgery, TTS fentanyl may require supplementation with parenteral opioids, local analgesics and NSAIAs. It is further recommended that where feasible the patch be applied 8-12h before surgical recovery, in order to achieve effective serum levels of analgesic.
Post-operative movements decreased by a factor of 2 to 3 on day 1 with sleeping bouts of up to 120min, where normal bouts in untreated animals were 20-30 min. This is most probably caused by a combination of post-operative morbidity, and surgery, coupled with the depressant and soporific effect of opioid compounds. Regardless of analgesic treatment, intervals between movements were increased over 3 days post-operatively and by day 3 were 1.5-4 times normal.
Figures 2-4 demonstrate that activity levels vary among similar sized and aged pigs in the absence of other treatments and may be useful primarily as a measure of state within the same animal. This is illustrated by the pre-treatment control activity level for a pig given buprenorphine (P18 , Fig 21which is almost double the levels seen in other groups. Variability in behaviour and activity among genetically similar pigs may in some respects be similar to the human situation in which activity levels and experience of pain vary widely according to sex, age, socioeconomic and cultural background and other factors (Crag 1986 ). Activity as a percentage of the 24 h day was not affected by the presence of fentanyl analgesia alone at either dose, indicating that at the serum concentration ranges seen in these groups (0.1-0.7 ng/ml) narcotization did not occur. More significantly, at these serum levels and employing a pure mu receptor agonist, the dysphoric reactions to other opioids previously reported in pigs (Hermansen et ai. 1986 ) did not occur. Animals treated with buprenorphine in the immediate peri-operative period required 'top-up' doses in order to achieve adequate pain control. By day 3 only the 25~lg/h fentanyl-treated group continued to have elevated pain scores (mean 7.7). With less adequate early pain control, the 25/lg/h group may have experienced more 'windup' related to chronic undertreated pain (Hall 1992 ) and hence a longer subsequent duration and intensity of pain.
The decrease in food consumption seen in all pigs between days 1 and 3 indicates that there may be a requirement for longer-term analgesic treatment in animals recovering from major surgery, at least longer than the traditional 2-3 post-operative days of analgesic therapy. Food intake appears to be a very robust indicator of post-operative morbidity in pigs, and increased as pain score levels decreased post-operatively.
In attempting to address the question of useful measures of effective pain control this case study was hampered by a lack of untreated controls which received no analgesia for comparison, by small numbers Laboratory Animals (2000) 34
Harvey-Clark, Gilespie & Riggs of subjects, and because it was a clinical study there were other variables which could not be controlled. It is also clear from the control behaviour indices in pigs that animals of the same sex and size, and from similar genetic backgrounds and environments have widely variable normal activity levels and pain responses. In this respect, pigs may be similar to humans where the individual differences in chronic pain experience are great. It appears that changing activity levels over 24 h periods relate to levels of post-operative pain and morbidity, however a much more extensive study would be required to fully characterize these changes. Decreased activity may also be caused by morbidity factors such as fever, inflammation and other processes associated with surgery and wound healing not associated directly with pain. In animals which had adequate clinical pain control such as those treated with the 50 /lg/h patch, activity levels were depressed on day 2. In this instance low pain scores indicate that decreased activity may be the equivalent of 'comfortable rest' and not a conclusive indicator of pain.
Of the objective methods employed for assessing state in pigs, food consumption has been one of the most easily measured and robust parameters (McGlone et al. 19931 . Food consumption was decreased to approximately 60% of normal or less up to 72 h post-operatively when pain scores and other parameters were considered near normal. However, food consumption alterations may not be a specific indicator of pain, as has been noted in laboratory rodent analgesia studies (Flecknell & Liles 19921 .The duration of depressed appetite indicates that the post-operative pain period may be longer than 48-72 h, and clinicians formulating pain management plans for animals receiving thoracotomy should consider this.
It appears that effective pain control produces a relatively inactive animal. Activity level decreased and interval between major movements increased after surgical invasion regardless of analgesic used. Effectiveness of pain control in animals treated with TIS fentanyl at the higher dose, 50/lg/h, equalled or exceeded that seen in pigs treated with buprenorphine. Because buprenorphine must be administered 2-3 times daily there are labour-based economic advantages to the use of TTS fentanyl. The cost of treatment with TTS fentanyl analgesia over a 3-day period is approximately one-quarter of the cost of parenteral buprenorphine for the same period. In addition TTS fentanyl produces steady-state serum levels of fentanyl that mimic a constant i.v. infusion, thus avoiding the peak/trough effect seen when intermittent parenteral analgesics are used. ITS products require less frequent disturbance of the animal during the post-operative period, important in helping to achieve rest and stability during convalescence particularly in labile species like the pig. This compound and delivery system has promise in the clinical setting as a basal analgesic in pigs. Furthermore its utility indicates the potential usefulness of the pig as a model for the study of transcutaneous drug delivery systems. 
